Carole Henry

Title: Carole Henry: Innovator in Biotechnology

Introduction

Carole Henry is a prominent inventor based in Besançon, France. She has made significant contributions to the field of biotechnology, particularly in the development of diagnostic tools and therapeutic proteins. With a total of 2 patents to her name, her work is paving the way for advancements in medical science.

Latest Patents

Carole's latest patents include innovative technologies such as the "Truncated CD20 protein, deltaCD20 - Diagnostic kit comprising an oligonucleotide probe for the mRNA encoding a polypeptide having an amino acid sequence substantially identical to that of SEQ ID NO: 2." Additionally, she holds a patent for the "Truncated CD20 protein, deltaCD20 - Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5."

Career Highlights

Carole is currently employed at Établissement Français du Sang, where she continues to innovate and contribute to the field of blood and tissue donation. Her work is crucial in enhancing the efficacy of treatments and diagnostics in healthcare.

Collaborations

Throughout her career, Carole has collaborated with notable colleagues such as Christophe Ferrand and Marina Deschamps. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Carole Henry's contributions to biotechnology through her patents and work at Établissement Français du Sang highlight her role as a leading inventor in her field. Her innovative spirit and dedication to improving medical diagnostics and treatments are commendable.